Haemonetics
HAE
#2913
Rank
S$7.21 B
Marketcap
S$158.42
Share price
1.60%
Change (1 day)
63.67%
Change (1 year)

EPS for Haemonetics (HAE)

EPS in 2026 (TTM): S$2.92

According to Haemonetics's latest financial reports the company's current EPS (TTM) is S$2.93. In 2025 the company made an earnings per share (EPS) of S$4.72 an increase over its 2024 EPS that were of S$3.31.

EPS history for Haemonetics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$2.92-38.08%
2025S$4.7242.68%
2024S$3.312.43%
2023S$3.2333.73%
2022S$2.41332.49%
2021S$0.56
2018S$1.15-363.15%
2017S-$0.44-207.1%
2016S$0.41-132.28%
2015S-$1.27-269%
2014S$0.75-20%
2013S$0.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.61 193.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$5.26 79.41%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
S$24.49 735.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$1.82-162.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
S$4.64 58.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
S$12.19 315.54%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
S$9.93 238.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus Corporation
CERS
S-$0.03868-101.32%๐Ÿ‡บ๐Ÿ‡ธ USA